• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中风患者基质金属蛋白酶-9(MMP-9)基因多态性

Matrix Metalloproteinase-9 (MMP-9) Gene Polymorphism in Stroke Patients.

作者信息

Buraczynska Kinga, Kurzepa Jacek, Ksiazek Andrzej, Buraczynska Monika, Rejdak Konrad

机构信息

Department of Neurology, Medical University of Lublin, Dr K. Jaczewskiego 8, 20-954, Lublin, Poland.

Department of Medical Chemistry, Medical University of Lublin, Lublin, Poland.

出版信息

Neuromolecular Med. 2015 Dec;17(4):385-90. doi: 10.1007/s12017-015-8367-5. Epub 2015 Sep 2.

DOI:10.1007/s12017-015-8367-5
PMID:26330106
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4643105/
Abstract

Matrix metalloproteinases (MMPs), endopeptidases degrading extracellular matrix, play an important role in the pathogenesis of atherosclerosis and vascular disease. The aim of this study was to evaluate the association between the C(-1562)T functional polymorphism in the MMP-9 gene and risk of stroke. We examined 322 patients with stroke and 410 controls. In the patient group, 52 % had type 2 diabetes. All subjects were genotyped for the C(-1562)T polymorphism by polymerase chain reaction and restriction analysis. A significant increase in T allele and CT + TT genotype frequencies was observed in patients compared with controls (OR 1.73, 95 % CI 1.34-2.23 and 1.89, 95 % CI 1.39-2.56, respectively). The T allele carriers were younger at the onset of stroke (63.5 ± 11.7 years) than patients with CC genotype (71 ± 14.1 years) (p = 0.0002). The comparison between patients with T2DM and without it showed that the T allele and CT + TT genotype were more frequent in T2DM patients (OR 1.48, 95 % CI 1.03-2.12 for T allele and 1.44, 95 % CI 1.93-2.24 for CT + TT genotype). In conclusion, our findings suggest that MMP-9 C(-1562)T polymorphism is significantly associated with risk of stroke in patients with and without T2DM.

摘要

基质金属蛋白酶(MMPs)是降解细胞外基质的内肽酶,在动脉粥样硬化和血管疾病的发病机制中起重要作用。本研究的目的是评估MMP - 9基因中C(-1562)T功能多态性与中风风险之间的关联。我们检查了322例中风患者和410例对照。在患者组中,52%患有2型糖尿病。通过聚合酶链反应和限制性分析对所有受试者的C(-1562)T多态性进行基因分型。与对照组相比,患者中T等位基因和CT + TT基因型频率显著增加(OR分别为1.73,95%CI为1.34 - 2.23和1.89,95%CI为1.39 - 2.56)。T等位基因携带者中风发病时比CC基因型患者年轻(63.5±11.7岁对71±14.1岁)(p = 0.0002)。有和没有2型糖尿病患者之间的比较表明,T等位基因和CT + TT基因型在2型糖尿病患者中更常见(T等位基因的OR为1.48,95%CI为1.03 - 2.12;CT + TT基因型的OR为1.44,95%CI为1.93 - 2.24)。总之,我们的研究结果表明,MMP - 9 C(-1562)T多态性与有和没有2型糖尿病患者的中风风险显著相关。

相似文献

1
Matrix Metalloproteinase-9 (MMP-9) Gene Polymorphism in Stroke Patients.中风患者基质金属蛋白酶-9(MMP-9)基因多态性
Neuromolecular Med. 2015 Dec;17(4):385-90. doi: 10.1007/s12017-015-8367-5. Epub 2015 Sep 2.
2
Matrix metalloproteinase-2 (MMP-2) gene polymorphism and cardiovascular comorbidity in type 2 diabetes patients.2型糖尿病患者基质金属蛋白酶-2(MMP-2)基因多态性与心血管合并症
J Diabetes Complications. 2015 Aug;29(6):829-33. doi: 10.1016/j.jdiacomp.2015.05.004. Epub 2015 May 14.
3
A functional single nucleotide polymorphism -1562C>T in the matrix metalloproteinase-9 promoter is associated with type 2 diabetes and diabetic foot ulcers.基质金属蛋白酶-9启动子区域功能性单核苷酸多态性-1562C>T与2型糖尿病及糖尿病足溃疡相关。
Int J Low Extrem Wounds. 2013 Sep;12(3):199-204. doi: 10.1177/1534734613493289. Epub 2013 Sep 16.
4
Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.基质金属蛋白酶 1、2、3 和 9 的功能性单核苷酸多态性与特发性复发性自然流产的关系。
Reprod Biomed Online. 2012 May;24(5):567-75. doi: 10.1016/j.rbmo.2012.01.008. Epub 2012 Jan 24.
5
Association of functional SNP-1562C>T in MMP9 promoter with proliferative diabetic retinopathy in north Indian type 2 diabetes mellitus patients.MMP9 启动子功能性 SNP-1562C>T 与北印度 2 型糖尿病患者增殖性糖尿病视网膜病变的关联。
J Diabetes Complications. 2017 Dec;31(12):1648-1651. doi: 10.1016/j.jdiacomp.2017.08.010. Epub 2017 Aug 26.
6
Genetic polymorphism c.1562C>T of the MMP-9 is associated with macroangiopathy in type 2 diabetes mellitus.MMP-9 基因 c.1562C>T 多态性与 2 型糖尿病大血管病变相关。
Biochem Biophys Res Commun. 2010 Jan 1;391(1):113-7. doi: 10.1016/j.bbrc.2009.11.012. Epub 2009 Nov 10.
7
Genetic variation of MMP-2(-735 C>T) and MMP-9(-1562 C>T) gene in risk of development of HAND and severity of HAND.基质金属蛋白酶-2(-735 C>T)和基质金属蛋白酶-9(-1562 C>T)基因的遗传变异与发生HAND的风险及HAND的严重程度
J Gene Med. 2016 Sep;18(9):250-7. doi: 10.1002/jgm.2897.
8
Association between the MMP-9-1562 C>T polymorphism and the risk of stroke: a meta-analysis.基质金属蛋白酶-9 -1562 C>T基因多态性与中风风险的关联:一项荟萃分析。
Mol Biol Rep. 2014 Oct;41(10):6787-94. doi: 10.1007/s11033-014-3564-0. Epub 2014 Jul 11.
9
Association of MMP-9 gene polymorphisms with atrial fibrillation in hypertensive heart disease patients.高血压性心脏病患者中基质金属蛋白酶-9基因多态性与心房颤动的关联
Clin Chim Acta. 2009 Oct;408(1-2):105-9. doi: 10.1016/j.cca.2009.07.020. Epub 2009 Aug 7.
10
Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene.携带基质金属蛋白酶-9基因启动子区域常见多态性(C-1562T)的中风患者接受组织纤溶酶原激活剂治疗的安全性概况。
Stroke. 2003 Dec;34(12):2851-5. doi: 10.1161/01.STR.0000098648.54429.1C. Epub 2003 Nov 6.

引用本文的文献

1
Identification of m6A-Related Biomarkers in Systemic Lupus Erythematosus: A Bioinformation-Based Analysis.系统性红斑狼疮中m6A相关生物标志物的鉴定:基于生物信息学的分析
J Inflamm Res. 2024 Jan 27;17:507-526. doi: 10.2147/JIR.S439779. eCollection 2024.
2
Identification of Molecular Mechanisms Responsible for the MMP-9-1562C/T Dependent Differential Regulation of Matrix Metalloproteinase-9 Expression in Human Neuron-like Cells.鉴定导致 MMP-9-1562C/T 依赖性基质金属蛋白酶-9 表达在人神经样细胞中差异调节的分子机制。
Genes (Basel). 2023 Oct 31;14(11):2028. doi: 10.3390/genes14112028.
3
Gene Polymorphism (rs3918242) Increases the Risk of Cardiovascular Disease in Type 2 Diabetes Patients.基因多态性(rs3918242)增加2型糖尿病患者患心血管疾病的风险。
J Clin Med. 2023 Nov 8;12(22):6990. doi: 10.3390/jcm12226990.
4
Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment.新型基质金属蛋白酶-9(MMP-9)抑制剂在癌症治疗中的应用。
Int J Mol Sci. 2023 Jul 28;24(15):12133. doi: 10.3390/ijms241512133.
5
Does the functional polymorphism-1562C/T of MMP-9 gene influence brain disorders?基质金属蛋白酶-9(MMP-9)基因的功能性多态性-1562C/T是否会影响脑部疾病?
Front Cell Neurosci. 2023 May 3;17:1110967. doi: 10.3389/fncel.2023.1110967. eCollection 2023.
6
Integrated bioinformatics and machine-learning screening for immune-related genes in diagnosing non-alcoholic fatty liver disease with ischemic stroke and RRS1 pan-cancer analysis.整合生物信息学和机器学习筛选免疫相关基因,用于诊断非酒精性脂肪肝合并缺血性脑卒中及 RRS1 泛癌分析。
Front Immunol. 2023 Apr 5;14:1113634. doi: 10.3389/fimmu.2023.1113634. eCollection 2023.
7
Matrix Metalloproteinases in Cardioembolic Stroke: From Background to Complications.心肌梗死后心脏破裂的危险因素分析
Int J Mol Sci. 2023 Feb 11;24(4):3628. doi: 10.3390/ijms24043628.
8
Matrix Metalloproteinase-9 as an Important Contributor to the Pathophysiology of Depression.基质金属蛋白酶-9是抑郁症病理生理学的重要促成因素。
Front Neurol. 2022 Mar 18;13:861843. doi: 10.3389/fneur.2022.861843. eCollection 2022.
9
Matrix Metalloproteinase-9 Gene Polymorphism and Its Methylation in Stroke Patients.基质金属蛋白酶-9基因多态性及其甲基化与中风患者的关系
Malays J Med Sci. 2021 Dec;28(6):32-41. doi: 10.21315/mjms2021.28.6.4. Epub 2021 Dec 22.
10
The Role of Biomarkers in Atherothrombotic Stroke-A Systematic Review.生物标志物在动脉粥样硬化性血栓性脑卒中的作用:系统综述。
Int J Mol Sci. 2021 Aug 21;22(16):9032. doi: 10.3390/ijms22169032.

本文引用的文献

1
Correlations between MMP-2/MMP-9 promoter polymorphisms and ischemic stroke.基质金属蛋白酶-2/基质金属蛋白酶-9启动子多态性与缺血性中风之间的相关性。
Int J Clin Exp Med. 2014 Feb 15;7(2):400-4. eCollection 2014.
2
Predilection role diabetes mellitus and dyslipidemia in the onset of ischemic stroke.糖尿病和血脂异常在缺血性卒中发病中的易患作用。
Med Arch. 2013;67(2):120-3. doi: 10.5455/medarh.2013.67.120-123.
3
The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke.基质金属蛋白酶(MMP)-2和MMP-9在缺血性卒中中的意义。
Int J Neurosci. 2014 Oct;124(10):707-16. doi: 10.3109/00207454.2013.872102. Epub 2014 Jan 16.
4
Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling.基质金属蛋白酶:血管生成和重塑中调节细胞行为的炎症调控因子。
Mediators Inflamm. 2013;2013:928315. doi: 10.1155/2013/928315. Epub 2013 Jun 12.
5
An overview of the genomics of metabolic syndrome.代谢综合征的基因组学概述。
J Nurs Scholarsh. 2013 Mar;45(1):52-9. doi: 10.1111/j.1547-5069.2012.01484.x. Epub 2013 Jan 31.
6
Changes in plasma matrix metalloproteinase-9 levels in patients with acute ischemic stroke.急性缺血性脑卒中患者血浆基质金属蛋白酶-9水平的变化
Rom J Intern Med. 2012 Apr-Jun;50(2):155-8.
7
Matrix metalloproteinases in vascular physiology and disease.基质金属蛋白酶在血管生理与疾病中的作用
Vascular. 2012 Aug;20(4):210-6. doi: 10.1258/vasc.2011.201202. Epub 2012 Aug 15.
8
Relationship between plasma metalloproteinase-9 levels and volume and severity of infarct in patients with acute ischemic stroke.血浆金属蛋白酶-9 水平与急性缺血性脑卒中患者梗死体积和严重程度的关系。
Acta Neurol Belg. 2012 Dec;112(4):351-6. doi: 10.1007/s13760-012-0067-4. Epub 2012 May 12.
9
Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study.糖尿病病程与缺血性脑卒中风险:北方曼哈顿研究。
Stroke. 2012 May;43(5):1212-7. doi: 10.1161/STROKEAHA.111.641381. Epub 2012 Mar 1.
10
Association between the -1562 C/T MMP-9 polymorphism and cerebrovascular disease in a Polish population.波兰人群中 MMP-9-1562C/T 多态性与脑血管病的相关性研究。
Neurol Neurochir Pol. 2010 Jul-Aug;44(4):350-7. doi: 10.1016/s0028-3843(14)60294-2.